Table 2.
Cytoplasmic and Membranous Expression of CD24 in Normal Ovaries and Benign and Malignant Ovarian Tumors
CD24 | Invasive carcinomas (n = 56; 100%) | Borderline tumors (n = 8; 100%) | Cystadenomas (n = 5; 100%) | Normal ovaries (n = 9; 100%) |
---|---|---|---|---|
Cytoplasmic | ||||
Negative | 23 (41.1%) | 7 (87.5%) | 5 (100%) | 9 (100%) |
Weak | 12 (21.4%) | 1 (12.5%) | 0 (0%) | 0 (0%) |
Moderate | 12 (21.4%) | 0 (0%) | 0 (0%) | 0 (0%) |
Strong | 9 (16.1%) | 0 (0%) | 0 (0%) | 0 (0%) |
Membranous | ||||
Negative | 5 (8.9%) | 2 (25%) | 5 (100%) | 9 (100%) |
Weak | 4 (7.1%) | 0 (0%) | 0 (0%) | 0 (0%) |
Moderate | 32 (57.1%) | 4 (50%) | 0 (0%) | 0 (0%) |
Strong | 15 (26.8%) | 2 (25%) | 0 (0%) | 0 (0%) |